Pharma business info

Relations between the administration and health experts dropped to a new low after Andrew Lansley charged them of contradicting his NHS reforms as they were disappoint about cuts to their salary as well as pensions.

RNA drug maker Alnylam Pharmaceuticals Inc. announced that it will slash around 33 percent of its jobs with the aim to diminish costs and concentrate on its most hopeful drug candidates

Innate Pharma SA (IPH), a French drug maker, grew up the most in over two months in Paris trading after the firm said a discovery released in the journal Science may give rise to novel infection fighting medications.

Cubist Pharmaceuticals stated that its fourth quarter profit declined by more than half owing to expenditures linked to its acquirement of constipation drug manufacturer Adolor Corp.